This effect is not simply a side consequence of illness but a direct biological result of how the cancer interacts with the body’s systems.
The Biochemistry of Trousseau’s Sign
For many years, doctors have recognized that unexplained blood clots can sometimes signal hidden cancers. In the 19th century, a French physician named Armand Trousseau observed that several patients experienced recurring clots long before their underlying cancers were diagnosed. This medical phenomenon later became known as Trousseau syndrome.
Modern research has since clarified the mechanisms behind this relationship. Advances in molecular biology have identified several biological “triggers” used by pancreatic tumors that interfere with the body’s clotting system.
Tissue Factor (TF) Overexpression
Pancreatic tumor cells release large amounts of a protein called Tissue Factor into the bloodstream. This protein functions as the body’s primary “emergency trigger” for blood clotting, initiating the coagulation cascade—the complex sequence of reactions that ultimately forms a clot.
In addition, cancer cells shed microscopic particles containing Tissue Factor into circulation. These particles travel throughout the bloodstream, spreading clot-promoting signals to distant areas of the body. They frequently lodge in the legs, where clot formation often occurs.
Adenocarcinoma Mucins
Another important contributor involves mucins—large, sugar-coated proteins produced by many pancreatic tumors. When these mucins enter the bloodstream, they behave like adhesive bridges, attaching to platelets and white blood cells. This interaction activates them in ways that strongly encourage clot formation, as described in research published in the Journal of Mind and Medical Science.
Together, these mechanisms create what physicians sometimes refer to as “sticky blood”—a condition in which the body’s natural clotting system remains continuously activated, making it far more likely for dangerous blockages to form.
Why the Legs Are Affected
According to research published in the National Library of Medicine, blood naturally moves more slowly through the deep veins of the legs than in many other parts of the body. This happens because gravity works against the upward flow of blood and because the legs are located far from the heart. As a result, this region is particularly vulnerable to the development of blood clots.
When abnormal clotting signals circulate throughout the body, the legs are one of the most frequent locations where a blockage can develop. As a clot begins to form, it disrupts normal blood flow and quickly leads to swelling and inflammation in the affected area. Some individuals may also notice pain, warmth, or redness, but for many patients the only visible warning sign is swelling in the leg.
Statistical Risks: The Khorana Score
Clinical evidence consistently confirms a strong relationship between pancreatic cancer and disorders involving blood clots. Among all cancers, pancreatic cancer ranks second for the risk of developing venous thromboembolism (VTE), a condition that includes both deep vein thrombosis (DVT) and pulmonary embolism.
NEXT PAGE
